\
&
Contact us
\
&
Contact us
Published on | 9 months ago
ProgrammesThe Digital Decade policy programme sets up a monitoring and collaboration mechanism based on common objectives and targets for 2030, in particular on digital infrastructure, digital skills, digitalisation of public services and digitalisation of businesses.
The Commission must review the programme by 30 June 2026 and may propose amendments. It will assess whether the programme and its implementation require changes in the light of technical, economic or societal developments and the evolution of EU priorities.
To gather input for this review, the Commission is currently collecting feedback from stakeholders. Contributing to the survey is possible until 23 December 2025 via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
